Search Results - "Danes, Jeanne M"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Mitochondrial Superoxide Dismutase: What the Established, the Intriguing, and the Novel Reveal About a Key Cellular Redox Switch by Palma, Flavio R, He, Chenxia, Danes, Jeanne M, Paviani, Veronica, Coelho, Diego R, Gantner, Benjamin N, Bonini, Marcelo G

    Published in Antioxidants & redox signaling (01-04-2020)
    “…Reactive oxygen species (ROS) are now widely recognized as central mediators of cell signaling. Mitochondria are major sources of ROS. It is now clear that…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    Estrogen Down-Regulation of the Corepressor N-CoR: Mechanism and Implications for Estrogen Derepression of N-CoR-Regulated Genes by Frasor, Jonna, Danes, Jeanne M., Funk, Cory C., Katzenellenbogen, Benita S., Chambon, Pierre

    “…The nuclear receptor corepressor N-CoR plays a crucial role in the repressive activity of diverse transcription factors, yet little is known about what…”
    Get full text
    Journal Article
  5. 5

    Arsenic and other metals as phenotype driving electrophiles in carcinogenesis by Danes, Jeanne M., Palma, Flavio R., Bonini, Marcelo G.

    Published in Seminars in cancer biology (01-11-2021)
    “…There are several sources of heavy metal exposures whether occupational or environmental. These are connected both with the existence of natural reservoirs of…”
    Get full text
    Journal Article
  6. 6

    Histone deacetylase inhibitor-based chromatin precipitation for identification of targeted genomic loci by Hanigan, Thomas W, Danes, Jeanne M, Taha, Taha Y, Frasor, Jonna, Petukhov, Pavel A

    Published in Journal of biological methods (30-03-2018)
    “…Histone deacetylase (HDAC) catalyzes the removal of acetyl marks from histones, effectively regulating gene expression. Genome wide chromatin…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer by El-Shennawy, Lamiaa, Dubrovskyi, Oleksii, Kastrati, Irida, Danes, Jeanne M, Zhang, Yiqun, Whiteley, Herbert E, Creighton, Chad J, Frasor, Jonna

    Published in Cancer research (Chicago, Ill.) (15-02-2018)
    “…A growing body of evidence suggests that the inflammatory NFκB pathway is associated with the progression of ER tumors to more aggressive stages. However, it…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer by Danes, Jeanne M., Abreu, Andre L. P., Kerketta, Romica, Huang, Yunping, Palma, Flavio R., Gantner, Benjamin N., Mathison, Angela J., Urrutia, Raul A., Bonini, Marcelo G.

    Published in The FASEB journal (01-12-2020)
    “…Inorganic arsenic (iAs/As2O32−) is an environmental toxicant found in watersheds around the world including in densely populated areas. iAs is a class I…”
    Get full text
    Journal Article
  11. 11
  12. 12

    A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction by Speltz, Thomas E, Danes, Jeanne M, Stender, Joshua D, Frasor, Jonna, Moore, Terry W

    Published in ACS chemical biology (16-03-2018)
    “…We and others have proposed that coactivator binding inhibitors, which block the interaction of estrogen receptor and steroid receptor coactivators, may…”
    Get full text
    Journal Article
  13. 13

    Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer by Brovkovych, Viktor, Izhar, Yasir, Danes, Jeanne M., Dubrovskyi, Oleskii, Sakallioglu, Isin T., Morrow, Lauren M., Atilla-Gokcumen, G. Ekin, Frasor, Jonna

    Published in Oncogenesis (New York, NY) (24-08-2018)
    “…Given the dependence of cancers on de novo lipogenesis, we tested the effect of fatostatin, a small molecule thought to target this pathway by blocking…”
    Get full text
    Journal Article
  14. 14

    Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype by Frasor, Jonna, Danes, Jeanne M, Komm, Barry, Chang, Ken C. N, Lyttle, C. Richard, Katzenellenbogen, Benita S

    Published in Endocrinology (Philadelphia) (01-10-2003)
    “…Estrogens are known to regulate the proliferation of breast cancer cells and to alter their cytoarchitectural and phenotypic properties, but the gene networks…”
    Get full text
    Journal Article
  15. 15

    Selective estrogen receptor modulators: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells by FRASOR, Jonna, STOSSI, Fabio, DANES, Jeanne M, KOMM, Barry, LYTTLE, C. Richard, KATZENELLENBOGEN, Benita S

    Published in Cancer research (Chicago, Ill.) (15-02-2004)
    “…Selective estrogen receptor modulators (SERMs) such as tamoxifen are effective in the treatment of many estrogen receptor-positive breast cancers and have also…”
    Get full text
    Journal Article
  16. 16

    Response-Specific and Ligand Dose-Dependent Modulation of Estrogen Receptor (ER) α Activity by ERβ in the Uterus by Frasor, Jonna, Barnett, Daniel H, Danes, Jeanne M, Hess, Rex, Parlow, Albert F, Katzenellenbogen, Benita S

    Published in Endocrinology (Philadelphia) (01-07-2003)
    “…Estrogen is of great importance in the regulation of uterine function. The aim of this study was to examine the individual physiological roles of each of the…”
    Get full text
    Journal Article
  17. 17

    Fatty acid desaturation and triglyceride accumulation protects breast cancer cells against fatostatin induced apoptosis by Brovkovych, Viktor, Danes, Jeanne M., Sakallioglu, Isin T., Atilla‐Gokcumen, G. Ekin, Frasor, Jonna

    Published in The FASEB journal (01-04-2017)
    “…Abstract only It is well established that cancer cells depend on de novo lipid synthesis to provide necessary membrane and signaling lipids for cell…”
    Get full text
    Journal Article
  18. 18

    Abstract 1810: Stapled peptide inhibitors of mutant estrogen receptor/coactivator interactions by Speltz, Thomas E., Danes, Jeanne M., Fanning, Sean W., Mayne, Christopher G., Tajkhorshid, Emad, Greene, Geoffrey L., Frasor, Jonna M., Moore, Terry W.

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract A current limitation in treating estrogen receptor-positive breast cancer is the development of resistance to endocrine therapy. Among the many…”
    Get full text
    Journal Article
  19. 19

    Selective Estrogen Receptor Modulators by Frasor, Jonna, Stossi, Fabio, Danes, Jeanne M., Komm, Barry, Lyttle, C. Richard, Katzenellenbogen, Benita S.

    Published in Cancer research (Chicago, Ill.) (15-02-2004)
    “…Abstract Selective estrogen receptor modulators (SERMs) such as tamoxifen are effective in the treatment of many estrogen receptor-positive breast cancers and…”
    Get full text
    Journal Article
  20. 20

    Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus by Frasor, Jonna, Barnett, Daniel H, Danes, Jeanne M, Hess, Rex, Parlow, Albert F, Katzenellenbogen, Benita S

    Published in Endocrinology (Philadelphia) (01-07-2003)
    “…Estrogen is of great importance in the regulation of uterine function. The aim of this study was to examine the individual physiological roles of each of the…”
    Get full text
    Journal Article